ST
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Assessing the impact of persistent HIV infection on innate lymphoid cells using in vitro models | ImmunoHorizons | 2023 | 82 | 100 | |||
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability | Frontiers in immunology | 2023 | 67 | 20 | |||
Dynamic single-cell regulomes characterize human peripheral blood innate lymphoid cell subpopulations | iScience | 2023 | 79 | 21 | |||
IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia | Haematologica | 2023 | 53 | 15 | |||
Dampening of cytotoxic innate lymphoid cells: A new tumour immune escape mechanism in B cell non-Hodgkin's lymphoma | Cellular immunology | 2022 | 190 | 79 | |||
Gliadin-reactive vitamin D-sensitive proinflammatory ILCPs are enriched in celiac patients | Cell reports | 2022 | 183 | 100 | |||
Development of human ILCs and impact of unconventional cytotoxic subsets in the pathophysiology of inflammatory diseases and cancer | Frontiers in immunology | 2022 | 178 | 189 | |||
c-Maf enforces cytokine production and promotes memory-like responses in mouse and human type 2 innate lymphoid cells | EMBO journal | 2022 | 294 | 221 | |||
Static adhesion assay for human peripheral blood mononuclear cells | Bio-protocol | 2022 | 182 | 77 | |||
PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions | Nature Communications | 2021 | 267 | 156 | |||
Healthy and patient type 2 innate lymphoid cells are differently affected by in vitro culture conditions | Journal of Asthma and Allergy | 2021 | 180 | 65 | |||
Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment | Cellular & Molecular Immunology | 2021 | 172 | 84 | |||
Human primed ILCPs support endothelial activation through NF-κB signaling | eLife | 2021 | 284 | 80 | |||
Sharpening of peripersonal space during the COVID-19 pandemic | Current Biology | 2021 | 157 | 126 | |||
Distinct and shared gene expression for human innate versus adaptive helper lymphoid cells | Journal of Leukocyte Biology | 2020 | 316 | 192 | |||
Immunosuppressive mediators impair proinflammatory innate lymphoid cell function in human malignant melanoma | Cancer Immunology Research | 2020 | 399 | 4 | |||
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes | Cancers | 2020 | 286 | 145 | |||
The pro- and anti-tumor role of ILC2s | Seminars in Immunology | 2019 | 244 | 0 | |||
ILC2s: new actors in tumor immunity | Frontiers in Immunology | 2019 | 293 | 104 | |||
Immunophenotyping of human innate lymphoid cells | Methods in Molecular Biology | 2019 | 242 | 1 | |||
Peripheral innate lymphoid cells are increased in first line metastatic colorectal carcinoma patients: a negative correlation with th1 immune responses | Frontiers in Immunology | 2019 | 229 | 98 | |||
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML | Blood Advances | 2019 | 392 | 202 | |||
ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells | Frontiers in Immunology | 2017 | 211 | 117 | |||
Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis | OncoImmunology | 2017 | 244 | 0 | |||
ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence | Journal of Clinical Investigation | 2017 | 273 | 124 | |||
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis | Nature Communications | 2017 | 432 | 122 |